The Acyl-CoA:Cholesterol acyltransferase (ACAT)-inhibitor avasimibe reduces atherosclerosis independently of its lipid-lowering effect in apoE3-Leiden mice

被引：0
|
作者：
Delsing, BDJM [1 ]
Offerman, EH [1 ]
van Duyvenvoorde, W [1 ]
Van der Boom, H [1 ]
Havekes, M [1 ]
Princen, HMG [1 ]
机构：
[1] Gaubius Lab, Leiden, Netherlands
来源：
CIRCULATION | 1999年 / 100卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3232
引用
收藏
页码：613 / 613
页数：1
相关论文
共 23 条
  • [1] Acyl-CoA: Cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden mice
    Delsing, DJM
    Offerman, EH
    van Duyvenvoorde, W
    van der Boom, H
    de Wit, ECM
    Gijbels, MJJ
    van der Laarse, A
    Jukema, JW
    Havekes, LM
    Princen, HMG
    CIRCULATION, 2001, 103 (13) : 1778 - 1786
  • [2] The acyl-CoA:Cholesterol acyltransferase inhibitor, avasimibe, effectively limits lipid storage in human macrophages
    Rodriguez, A
    Wee, SB
    Usher, DC
    CIRCULATION, 1999, 100 (18) : 613 - 613
  • [3] Human Acyl-CoA:Cholesterol acyltransferase (ACAT) and its potential as a target for pharmaceutical intervention against atherosclerosis
    Chang, C
    Dong, RH
    Miyazaki, A
    Sadashita, N
    Zhang, Y
    Liu, J
    Guo, M
    Li, BL
    Chang, TY
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2006, 38 (03) : 151 - 156
  • [4] Human Acyl-CoA:cholesterol Acyltransferase (ACAT) and its Potential as a Target for Pharmaceutical Intervention against Atherosclerosis
    Catherine CHANG
    Ruhong DONG
    Akira MIYAZAKI
    Naomi SAKASHITASecond Department of Pathology
    Jay LIU
    Michael GUO
    Acta Biochimica et Biophysica Sinica, 2006, (03) : 151 - 156
  • [5] Acyl-CoA: Cholesterol acyltransferase inhibition reduces atherosclerosis in apolipoprotein E-deficient mice
    Kusunoki, J
    Hansoty, DK
    Aragane, K
    Fallon, JT
    Badimon, JJ
    Fisher, EA
    CIRCULATION, 2001, 103 (21) : 2604 - 2609
  • [6] Adrenocortical lipid depletion gene (ald) in AKR mice is associated with an acyl-CoA:cholesterol acyltransferase (ACAT) mutation
    Meiner, VL
    Welch, CL
    Cases, S
    Myers, HM
    Lusis, HAJ
    Farese, RV
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (02) : 1064 - 1069
  • [7] Plaque stabilization of the novel acyl-CoA:cholesterol acyltransferase inhibitor, K-10191, in apoE knockout mice
    Kobayashi, H
    Kawamine, K
    Yoshinaka, Y
    Shibuya, K
    Sato, F
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 161 - 161
  • [8] Cholesterol-lowering effects of NTE-122, a novel acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor, on cholesterol diet-fed rats and rabbits
    Azuma, Y
    Kawasaki, T
    Ikemoto, K
    Obata, K
    Ohno, K
    Sajiki, N
    Yamada, T
    Yamasaki, M
    Nobuhara, Y
    JAPANESE JOURNAL OF PHARMACOLOGY, 1998, 78 (03): : 355 - 364
  • [9] Tomatidine, a Tomato Sapogenol, Ameliorates Hyperlipidemia and Atherosclerosis in ApoE-Deficient Mice by Inhibiting Acyl-CoA:cholesterol Acyl-transferase (ACAT)
    Fujiwara, Yukio
    Kiyota, Naoko
    Tsurushima, Keiichiro
    Yoshitomi, Makiko
    Horlad, Hasita
    Ikeda, Tsuyoshi
    Nohara, Toshihiro
    Takeya, Motohiro
    Nagai, Ryoji
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2012, 60 (10) : 2472 - 2479
  • [10] Effect of F-1394, an acyl-CoA:cholesterol acyltransferase inhibitor, on atherosclerosis induced by high cholesterol diet in rabbits
    Aragane, K
    Kojima, K
    Fujinami, K
    Kamei, J
    Kusunoki, J
    ATHEROSCLEROSIS, 2001, 158 (01) : 139 - 145
123